Get the Stockscreener App
103.12
1.48%
1.50
After Hours:
102.81
-0.31
-0.30%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $103.12, with a volume of 9.17M.
It is up +1.48% in the last 24 hours and down -0.83% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
See More
Previous Close:
$101.62
Open:
$101.65
24h Volume:
9.17M
Relative Volume:
0.96
Market Cap:
$260.72B
Revenue:
$63.17B
Net Income/Loss:
$12.15B
P/E Ratio:
57.29
EPS:
1.8
Net Cash Flow:
$14.84B
1W Performance:
+5.83%
1M Performance:
-0.83%
6M Performance:
-20.36%
1Y Performance:
+1.67%
1-Day Range:
$101.64
$103.45
1-Week Range:
$96.95
$103.45
52-Week Range:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
103.12 | 260.72B | 63.17B | 12.15B | 14.84B | 1.80 |
|
LLY
Lilly Eli Co
|
788.19 | 752.65B | 40.86B | 8.37B | -2.28B | 5.4193 |
|
NVO
Novo Nordisk Adr
|
106.13 | 471.56B | 39.36B | 13.79B | 9.83B | 2.4077 |
|
JNJ
Johnson Johnson
|
155.40 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
|
ABBV
Abbvie Inc
|
183.08 | 323.72B | 55.53B | 5.12B | 15.62B | 3.65 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.5%What's Next? - MarketBeat
FORA Capital LLC Purchases New Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
MetLife Investment Management LLC Sells 18,630 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
BNP Paribas Has $36.39 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
Bridgewater Associates LP Sells 247,721 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Glenmede Trust Co. NA Acquires 415,340 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Townsquare Capital LLC Acquires 9,305 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Loomis Sayles & Co. L P Acquires 56,495 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock rises Tuesday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.3%Time to Sell? - MarketBeat
$14.58 Bn Meningococcal Vaccines Market Assessment (2023-2034) by Type, Brand, Age Group, Serotype, End-user and Region - GlobeNewswire Inc.
Thematics Asset Management Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Shum Financial Group Inc. Invests $829,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Lazard Freres Gestion S.A.S. - MarketBeat
Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China - Insider Monkey
D.A. Davidson & CO. Has $63.58 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Fmr LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
The Manufacturers Life Insurance Company Buys 145,333 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck CEO to Present at Citi Global Healthcare Conference 2024 | MRK Stock News - StockTitan
Merck & Co., Inc. (NYSE:MRK) Trading 1.4% HigherWhat's Next? - MarketBeat
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co., Inc. (MRK) Announces New Board Appointment and By-Law Amendments - GuruFocus.com
Why Is Merck Stock Trading Higher On Monday? - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Qsemble Capital Management LP - MarketBeat
Private Trust Co. NA Lowers Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Horizon Kinetics Asset Management LLC - MarketBeat
Mirabella Financial Services LLP Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: successful study in arterial hypertension - Marketscreener.com
Davis R M Inc. Has $35.49 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Trimmed by Douglass Winthrop Advisors LLC - MarketBeat
Fisher Asset Management LLC Has $1.66 Billion Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck's therapy for rare lung condition shown to help reduce risk of death in study - Reuters
Merck Announces Pivotal Phase 3 Zenith Trial Evaluating Winrevair Met Primary Endpoint At Interim Analysis - Marketscreener.com
Westfield Capital Management Co. LP Has $13.31 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Q4 EPS Forecast for Merck & Co., Inc. Decreased by Analyst - MarketBeat
Daiwa Securities Group Inc. Grows Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
20,922 Shares in Merck & Co., Inc. (NYSE:MRK) Bought by Segall Bryant & Hamill LLC - MarketBeat
Hedge Funds Bet Big On Merck & Co. (MRK): Top Healthcare Stock to Watch - Insider Monkey
M Holdings Securities Inc. Sells 35,264 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Boosted by Kingsview Wealth Management LLC - MarketBeat
Cerity Partners LLC Boosts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Great Valley Advisor Group Inc. - MarketBeat
Landscape Capital Management L.L.C. Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck recommends rejection of TRC Capital’s 'mini-tender' offer - Seeking Alpha
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer - Business Wire
Merck & Co., Inc. (NYSE:MRK) Trading 1.3% HigherHere's What Happened - MarketBeat
Surendralal Karsanbhai Elected to Merck Board of Directors - BioSpace
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Icon Wealth Advisors LLC - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):